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Abstract
Background: As we known, Traditional Chinese Medicine (TCM) helps to prevent the relapse of drug addiction.
However, the scientific basis of TCM remains unclear because of limitations of current reductionist approaches. We
aimed to explore the possible mechanism of how ANKK1 TaqIA (A1/A2) [rs1800497(T/C)] affects the relapse of opioid
addiction on the perspective of Chinese traditional medicine.
Methods: The ANKK1 TaqIA (A1/A2) [rs1800497(T/C)] of the dopamine D2 receptor (DRD2) polymorphisms were
genotyped in a case–control sample consisting of 347 opioid addicts and 155 healthy controls with RT-PCR and the
TCM pathological factors were collected by means of Syndrome Elements Differentiation in the case–control sample.
Results: DRD2/ANKK1 TaqIA Polymorphisms has no relation with opioid addiction relapse; but for those who were
diagnosed with phlegm syndrome, DRD2/ANKK1 TaqIA Polymorphisms affect the replapse of apioid addiction (P < 0.05).
Conclusions: DRD2/ANKK1 TaqIA is associated with opioid addict and it is obvious in opioid addicts who suffer from
the phlegm syndrome.
Keywords: Opioid addicts, Syndrome element, Phlegm syndrome, DRD2/ANKK1 TaqIA, Polymorphism
rs1800497,32806C/T
Background
Opioid addiction, a kind of chronic brain disease relapses,
which is caused by abuse of heroin, morphine, interacts
with the reward system of brain [1]. An interesting
hypothesis has arisen from the possible roles of decreased
dopamine receptor density resulting in Reward Deficiency
Syndrome [2]. Reward Deficiency Syndrome is character-
ized by a lower basal dopamine level because of insuffi-
cient receptor capacity, resulting in a need of a certain
amount of dopamine to feel good (this could be achieved
by rewarding experiences such as drugs, gambling,
alcohol, etc.). Studies on animal models further under-
line the role of DRD2 in drug addiction as the reward-
ing effects of opiates were found absent in mice lacking
the D2 receptor gene [3, 4]. Genetic polymorphisms
of the dopaminergic system include single nucleotide
polymorphisms (SNPs) and length polymorphisms of the
receptors, transporters and metabolizing enzymes.
The dopamine D2 receptor (DRD2) was characterized
previously with TaqIA, TaqIB, and TaqID SNPs based on
restriction digestion of this region with the TaqI enzyme.
Early studies indicated the A1 allele of TaqIA(or the T
allele of rs1800497) as a risk factor of substance abuse,
alcoholism [5] and heroin dependence [6], but some
studies have failed to replicate these findings [7, 8]. Later
it turned out that theTaqIA restriction fragment length
polymorphism (RFLP) is located approximately 10 kilo-
bases downstream from the DRD2 gene, in exon 8 of the
ANKK1 (ankyrin repeat and kinase domain containing 1)
gene [9], which is a member of the serine/threonine kinase
family. The TaqIA polymorphism, causing an amino acid
change in ANKK1 (Glu713Lys), seems to have a significant
effect on the specificity of substrate binding. The protein
product of the ANKK1 gene was considered as a nega-
tive regulator of the NF-κB (Nuclear Factor-KappaB)
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transcription factor [10]. Moreover, the expression level
of NF-κB-regulated genes was shown to be altered by
TaqIA variants in an in vitro luciferase system [11].
Since DRD2 is regulated by NF-κB [12, 13], it could be
assumed that this ANKK1 variant can indirectly affect
DRD2 receptor density. Growing evidence indicated
conflicting results about the dopamine receptor D2
(DRD2)/ANKK1)TaqIA single nucleotide polymor-
phism(rs1800497,32806C/T) and common illicit drug
dependence risk including stimulants, opioid and
marijuana. In recent years, The meta-analysis suggested
that DRD2/ANKK1 TaqIA polymorphism might be associ-
ated with opioid dependence risk [14].
But not all the results of study with DRD2/ANKK1
TaqIA and drug addiction are the same. Apart from the
reason of gender, race, the individual reflection environ-
ment, natural condition may be one of the main reasons,
and leads to different results. TCM theory is a holistic
view. The doctor of traditional Chinese medicine will
consider what you eat, what you do, and how you feel
before giving treatment. Carrying out a study by using
traditional Chinese medicine methodology, we may dis-
cover some different results from previous studies.
Traditional Chinese Medicine has been practiced in
China for more than 2000 years, and for the past 200
years, it has been used in treatment of opioid addiction.
It is the fact that TCM is effective in controlling opiate
withdrawal symptoms and preventing opiate relapse with
fewer side effects. In Traditional Chinese Medicine (TCM)
theory, the common TCM pathological factors that may
induce addiction relapse are yang deficiency, blood heat,
and phlegm, among which the most prominent one is
phlegm [15], while it is still an unresolved question about
how phlegm induces relapse. In order to investigate the
association between phlegm and DRD2/ANKK1 TaqIA
which plays a key role in relapse, we collected 347 cases
for DRD2/ANKK1 TaqIA genotyping, and tried to figure
out its relationship with the Traditional Chinese Medicine
pathological factors of opioid addiction.
Materials and methods
Study object
Participants were recruited from November 2008 to
December 2012 in Fuzhou City, Fujian Province, China.
We recruited 347 opioid addicts from two drug rehabili-
tation centres (167 subjects came from the drug rehabili-
tation centers under the jurisdiction of the Department
of Public Security of Fujian Province and 180 subjects
came from the drug rehabilitation centers under the juris-
diction of the Department of Justice of Fujian Province).
The experimental procedures and protocol were approved
by the Ethical Committee of Fujian University of
Traditional Chinese Medicine. Informed consent forms
were signed by all subjects before the study. Figs. 1, 2,
and 3 provide the characteristics of the participants, in-
cluding their age, gender.
All these opioid addiction subjects met the Diagnostic
and Statistical Manual of Mental Disorders-IV, followed
completion of a 3- month detoxification-treatment, and
had no history of mental illness, agreed to participate in
this survey. All of them could understand and correctly
answer the various assessment tools, and cooperated to
complete the questionnaires. Those with liver, kidney,
cardiac insufficiency, and those psychopaths who could
not cope with the survey were excluded.
The healthy control group: 155 students were randomly
selected from schools who were healthy and ranged from
18 to 25 years old without illicit drug addiction, alcohol
addiction, smoking and other drug addiction. (Sex ratio of
both drug group and health control group had no signifi-
cant difference, P < 0.05) ( Fig. 4).
Procedure
All subjects participated in a 12-h overnight rapid blood
draw. Trained research assistants then completed a sur-
vey of physiological characteristics for all participants,




TCM Syndrome differentiation (also known as ZHENG
differentiation) is a process of analyzing data collected
through four combined diagnostic methods: inspection,
auscultation and olfaction, inquiry, and the palpation is
a distinguishing feature of TCM. According to TCM
theory, Prof. Wenfeng Zhu established the Syndrome
Elements (ZHENG Elements) Differentiation method
[16], and it is recognized by Diagnostics of Traditional
Chinese Medicine Branch of China Association of Chinese
Medicine. This method is used in China to identify TCM
syndrome. The criteria of which is set up by statis-
tical means to explore the relationship between TCM
syndrome and clinical symptoms of patients. Trad-
itionally, people can be diagnosed with certain TCM
syndrome through the four-diagnostic methods, with
certain degree of subjectivity and ambiguity from in-
dividual doctors. But according to this method, TCM
Syndrome differentiation become objectified by statis-
tical means.
What are TCM syndrome elements? For example, if a
patient is diagnosed as syndrome “liver Yin deficiency”,
according to this method, we could get two TCM syn-
drome elements: one is Liver ,the other is Yin deficiency.
Prof. Zhu Wenfeng calculated the percentage of each
symptom appearing in certain TCM syndrome elements
through epidemiology studies of large sample, by in-
vestigating TCM disease cases books in history and
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consulting prestigious TCM doctors by Delphi method
and then concluded how important a symptom can con-
tribute to certain TCM syndrome element by weighting
each symptom with certain integral. Hence, in this
method, you can find a certain integral of each symptom
which is related to a certain TCM syndrome element.
Once the sum of integrals of all symptoms relating to
certain syndrome element is equal to or above 100, cer-
tain syndrome element is accepted as part of diagnosis
for a patient. For example, the patient’s syndrome is yel-
lowing of the skin, (in TCM Theory, skin becoming
yellow is relevant to Liver), so it is 40 of symptom
“yellowing of the skin”, which contributes to syndrome
element “Liver”, according to Wenfeng III Auxiliary
Diagnosis and Treat System of TCM [17–19]. Once the
sum of integrals of syndrome element is equal to or
above 100, certain syndrome element is accepted as part
of diagnosis for a patient.
Method
Drug Abuse and Opioid Addiction Severity Inventory
(OASI) [20] and The Syndrome Differentiation Signifi-
cance of 600 Kinds of Common Symptom [16] were
used. The drug group’s four kinds of diagnostic infor-
mation were collected and the simultaneous acquisition
was required to achieve the objectivity and accuracy.
Syndrome Elements Differentiation method was used for
reference. Through preliminary experiments, “the TCM
syndrome scale for Drug abusers in Fujian province”
was designed by trained and professional personnel to
investigate objects, item by item.
Genotyping
DNA was extracted using standard Methodology. The
assay reagents for SNP genotyping consisted of a mix of
PCR primers and TaqMan MGB probes (FAM and VIC
labeled) that were obtained from Applied Biosystems
(Foster City, CA, USA). TaqMan SNP Genotyping Assays
(ABI) were used for the polymorphisms ANKK1
rs1800497. Probes and primer for the DRD ANKK1




CAGGCGCCCAGCTGGACGTCCA (5′-3′). Each assay
enables scoring of both alleles in a single well within a
384-well plate. All assays were optimized to work with
genomic DNA and TaqMan Universal Master Mix from
Applied Biosystems. Forty cycles of PCR were per-
formed. Plates were analyzed using an ABI Prism
7900HT Sequence Detection System from Applied
Biosystems.
Statistical analysis
The questionnaire data entry was processed by Access
2000 software, and a database was set up, then the cal-
culation of the allele and genotype frequencies and
Hardy-Weinberg equilibrium test. Chi-square test was
Fig. 1 The age distribution of opioid addiction subjects in the present study
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analyzed by SPSS 19.0 software, and statistical analysis
of differences in each group allele and genotype fre-
quency distribution was carried out, then came correl-
ation between genotype and syndrome factor using a
stepwise logistic regression mode.
Results
Relationship between Syndrome Elements and opioid
addiction
The main Syndrome Elements we collected is shown in
Fig. 5, and qi deficiency, liver, yang deficiency are com-
mon among opioid addicts. We found the more inci-
dences of drug treatment one person has, the stronger
addiction intensity he has, so we weighted “Addiction
intensity” as follows:first time =1; more than twice
(including 2 times) = 2. The age, gender and duration
of drug use (years) had no difference in opioid addicts
who have different addiction intensity. A stepwise logistic
regression mode was used when age and gender were
always included to analyze the relationship between
Syndrome Elements and opioid addiction. In the mode,
the integral of each TCM syndrome element is the
independent variable, and addiction intensity is the
dependent variable. The stronger the addiction intensity
is, the more possible the relapse will come.
As shown in Table 1, phlegm, qi deficiency, damp evil,
blood stasis, lung and heart emotion are significantly
associated with addiction relapse, comprising phlegm
qi deficiency (P = 0.000, 95 % CI:,0.708 to 0.962).
This shows that people with phlegm syndrome element
(P = 0.000, 95 % CI:1.131 to1.287) or qi deficiency syn-
drome element(P = 0.001, 95 % CI:1.021 to 1.051) have
stronger addiction intensity and are more likely to
relapse. Damp evil(P = 0.000, 95 % CI:0.915 to0.966), blood
stasis(P = 0.008, 95 % CI:0.954 to0.988), lung(P = 0.000,
95 % CI:0.823 to0.930) and heart emotion(P = 0.000,
95 % CI:0.883 to0.960) are the protective factors of
addiction relapse. According to the result, phlegm, qi
deficiency, damp evil, blood stasis, lung and heart
emotion are the TCM pathological factors which affect
the relapse of opioid addiction.
DRD2/ANKK1 TaqIA Distribution
DRD2/ANKK1 TaqIA genotype and allele frequency dis-
tribution are shown in Table 2. The distribution of the
DRD2/ANKK1 TaqIA was in Hardy-Weinberg (HW)
equilibrium (P > 0.05), and the distribution did not differ
between the females and males, the opioid addicts and
the health group, respectively. To further determine dif-
ferential distribution in opioid addicts, we carried out
Pearson Chi-square Test. We find there is no difference
in opioid addicts who have different Addiction inten-
sities (Table 2).
Relationship between TCM pathological factors of opioid
addiction and DRD2/ANKK1 TaqIA
As we known, the distribution of DRD2/ANKK1 TaqIA
has no difference in opioid addicts who have different
addiction intensities, and we find there is no relationship
between the DRD2/ANKK1 TaqIA and Syndrome
Elements by using one-way analysis of variance (Table 3).
Furthermore, we applied a stepwise logistic regression
model to DRD2/ANKK1 TaqIA, Syndrome Elements and
Addiction intensity to explore the relevance between
them. As shown in Table 4, the genotype of DRD2/
ANKK1 TaqIA has no relationship with addiction inten-
sity, and if excluded from the model, the interaction of
DRD2/ANKK1 TaqIA and phlegm is an important factor
in the addiction intensity. The DRD2/ANKK1 TaqIA
genotype(A2A2) could add addiction intensity (P = 0.007,
Fig. 2 The gender distribution of opioid addiction subjects in the
present study
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95 % CI:0.995 to1.021) relative to TaqIA genotype(A1A1).
The influence of the heterozygote(A1A2) was he same
with genotype(A1A1), so we could find A2 is an risk
factor of addiction relapse, when phlegm exists.
Discussion
Relapse is a complex pathological behavior, caused by
the combination of the pathological psychological,
pathophysiological and social environmental factors [21].
Besides genetics, age, sex, diet, spirit endures, it is widely
believed in China that Zang-Fu function, Qi-blood and
Body fluids change in TCM theory have association with
drug relapse behavior. While currently, relevant studies
are scarce.
TCM is a holistic and systematic medicine, and
Syndrome Elements Differentiation method based on
TCM Syndrome Differentiation was used to extract
TCM pathological factors. Our statistics results suggest
that in both group1 and group2, phlegm is a risk factor
for addiction relapse. And qi stagnate, damp are protec-
tion factors, which is consistent with our previous
findings [15].
Dopamine receptors belong to the G protein coupled
receptor family. Studies have shown that DRD2 gene
knockout mice had failed to react to opioids reward
[22], showing that DRD2 plays an important role in drug
addiction. DRD2 gene is located in human genome
Fig. 3 The incidences of drug treatment in opioid addiction subjects
Fig. 4 The gender distribution of health group in the present study
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11q22 near the outer 8 exon 3′- untranslated region
which contains a TaqIA polymorphism. Among them
there are A1, A2 allele. The correlation between the
above site and drug addiction has previously been re-
ported [23–25]. In our study, the results indicate that
the distribution of genotypes and allele frequencies be-
tween the drug group and the normal control group
showed no significant difference (P > 0.05), which is con-
trary to the results of previous studies. The reasons we
assume are as follows: first, there are varying gene fre-
quency distributions among different geographic regions;
second, different drugs using and short-term drug
dependence might deviate the experiment result.
Long-term opioid abuse caused Qi-blood disturbance,
and Qi and blood were consumed, then leading to
dysfunction of the zang-fu organs, and producing all
sorts of Traditional Chinese Medicine pathological
factors. The performance of opioid addicts show that
their oral secretions increased, be easy to fatigue, in the
bad emotional state, and so on, which is related with
phlegm, qi deficiency, damp evil, and anther Traditional
Chinese Medicine pathological factors, especially phlegm.
Yawning, runny nose, tears, and frequently increasing
oral secretions arose during Drug addiction episodes.
That is the same with the performance of phlegm syn-
drome. And the previous data mining research on the
relationship between the loci and addiction relapse
shows once phlegm symptom was present, the addic-
tion of patients who carry the A2A2 allele have more
possibilities to relapse than those with genotype A1A1.
According to our former research, phlegm syndrome is
a major cause of addiction relapse, but the mechanism
about how phlegm is involved is still a question. From
the results of the current data, we found A2A2 had
no effect on addiction relapse when TCM factors are
not involved. However when DRD2/ANKK1 TaqIA stay
with phlegm, it becomes an important factor for the
addiction relapse. And A2A2 is a risk factor for addic-
tion relapse. According to the above results we explain
as follows: first, phlegm causes addiction relapse, but
has no relation with the genotype. The other explan-
ation is phlegm syndrome may affect the expression by
modifying the allele through epigenetic mechanisms,
thus leading to relapse. In modern research, investiga-
tors found opioid receptor gene (OPPM1) was highly
methylated in the blood and semen of patients with
opioid addiction [26]. This indicates long-term drug
Fig. 5 The main Syndrome Elements of opioid addicts
Table 1 Relationship between Syndrome Elements and opioid
addiction
Participant characteristics P OR CI(95 %)
Age 0.104 1.089 0.983-1.207
Gender 0.444 1.813 0.396-8.312
Phlegm 0.000 1.206 1.131-1.287
Damp evil 0.000 0.940 0.915-0.966
Blood stasis 0.008 0.954 0.921-0.988
Qi deficiency 0.001 1.031 1.012-1.051
Lung 0.000 0.875 0.823-0.930
Heart emotion 0.000 0.920 0.883-0.960
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dependence is related to epigenetic. The contemporary
epigenetic theory researchers believe that at every stage
of life, genome and epigenome damage are associated
with the harmful health factors. When exposed to the a
particular environment, defect metabolic process or
improper supply of trace elements are involved in DNA
synthesis, DNA damage repair, and DNA normal
methylation process. Currently, more and more studies
show phlegm has close relationship with energy metab-
olism and the immune system, and it could lead to
form a particular environment in the body that is con-
ducive to epigenetic. And in that situation, charming
away phlegm will help addicts to recover from drug
addiction. As in the related researches, An-jun-ning, a
traditional herbal formula that could reduce phlegm,
may help to prevent relapse in opioid dependence treat-
ment. Studies find AJN can effectively alleviate opioid
withdrawal symptoms and preserve or restore the DAT,
D2R, TH levels in the striatum. The mechanism under-
lying the effect of AJN on withdrawal symptoms may
be related to the modulation of the dopamine system
by AJN [27]. Consequently, we hypothesized that the
normal DNA methylation is disturbed when the spu-
tum symptom starts to interfere with the metabolic
process.
In this research, we also found other TCM patho-
logical factors associate with addiction relapse, and
phlegm is not an independent risk factor. But in this
paper; we discussed phlegm syndrome only, the
mechanism of the other TCM pathological factors is
still unclear.
Table 2 DRD2 TaqIA genotypic distribution and allelic frequencies
Genotypic Distribution (%) Allele Frequency (%)
Group A1A1 A1A2 A2A2 A1 A2 HWEP-value
Full (n = 502) 71 (14.1) 252 (50.2) 179 (35.7) 394 (39.2) 610 (60.8) 0.238
Males (n = 289) 39 (13.5) 137 (47.4) 113 (39.1) 215 (37.2) 363 (62.8)
Females (n = 213) 32 (15.0) 115 (54.0) 66 (31.0) 179 (42.0) 247 (58.0)
Opioid addicts (n = 347) 50 (14.4) 168 (48.4) 129 (37.2) 268 (38.6) 426 (61.4) 0.692
Health group (n = 155) 21 (13.5) 84 (54.2) 50 (32.3) 126 (40.6) 184 (59.4) 0.125
Addiction intensity = 1 26 (7.49) 88 (23.4) 58 (16.7) 140 (20.2) 204 (29.4)
Addiction intensity = 2 24 (6.91) 81 (23.3) 70 (20.2) 129 (18.6) 221 (31.8)
Genotype comparison between males and females: χ2 = 3.53, df = 2, p = 0.171
Genotype comparison between opioid addicts and health group: χ2 = 1.034, df = 2, p = 0.596
Genotype comparison between different addiction intensities: χ2 = 1.469, df = 2, p = 0.480
Full: includes both males and females
Hardy-Weinberg equilibrium of genotype distributions of each polymorphism was tested for all of the participants, opioid addicts, and health group
Table 3 Relationship between the DRD2/ANKK1 TaqIA and
Syndrome Elements
Syndrome Elements F P
Qi deficiency 0.048 0.953
Liver 0.397 0.692
Yang deficiency 0.077 0.926
Yin deficiency 0.367 0.693
Qi stagnation 0.206 0.814
Phlegm 0.430 0.651
Kidney 0.016 0.984
Blood deficiency 0.004 0.996
Spleen 0.031 0.970
Dampness pathogen 0.236 0.790
Heat pathogen 0.492 0.612
Heart 0.208 0.813
Stomach 0.466 0.628
Heart emotion 1.157 0.316
Lung 0.215 0.807
Blood stasis 0.032 0.968
Table 4 Relationship between TCM pathological factors of
opioid addiction and DRD2/ANKK1 TaqIA
Participant characteristics P OR CI(95 %)
age 0.424 1.043 0.941-1.154
gender 0.274 2.679 0.458-15.668
phlegm 0.000 1.305 1.159-1.470
damp evil 0.000 0.914 0.872-0.986
blood stasis 0.010 0.941 0.889-0.986
qi deficiency 0.002 1.048 1.017-1.080
lung 0.000 0.818 0.740-0.914
heart emotion 0.000 0.870 0.808-0.937
DRD2/ANKK1TaqIA * phlegm 0.014
DRD2/ANKK1TaqIA(A2A1) * phlegm 0.225 1.008 0.995-1.021
DRD2/ANKK1TaqIA(A2A2) * phlegm 0.007 1.027 0.995-1.021
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Conclusion
DRD2/ANKK1 TaqIA polymorphism is associated with
opioid dependence risk, when individual is diagnosed
with phlegm syndrome. We suspect that plegm syn-
drome could lead to form a particular environment in
the body that is conducive to epigenetics of DRD2/
ANKK1 TaqIA, further caused the addiction relapse.
Further studies are needed to discover the specific
mechanism. Epigenetic experiment is also necessary.
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